These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19281096)

  • 1. Geographic differences in clinical characteristics and management of COPD: the EPOCA study.
    Miravitlles M; Murio C; Tirado-Conde G; Levy G; Muellerova H; Soriano JB; Ramirez-Venegas A; Ko FW; Canelos-Estrella B; Giugno E; Bergna M; Chérrez I; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):803-14. PubMed ID: 19281096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to a COPD treatment guideline among patients in Hong Kong.
    Chan KP; Ko FW; Chan HS; Wong ML; Mok TY; Choo KL; Hui DS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3371-3379. PubMed ID: 29238182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
    Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan.
    Yamamoto T; Oishi K; Ohata S; Murata Y; Yamaji Y; Asami-Noyama M; Edakuni N; Kakugawa T; Hirano T; Matsunaga K
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1123-1130. PubMed ID: 38803411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study.
    Suerdem M; Gunen H; Akyildiz L; Cilli A; Ozlu T; Uzaslan E; Abadoglu O; Bayram H; Cimrin AH; Gemicioglu B; Misirligil Z
    Int J Chron Obstruct Pulmon Dis; 2020; 15():261-267. PubMed ID: 32103925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.
    Franssen FM; Spruit MA; Wouters EF
    Int J Chron Obstruct Pulmon Dis; 2011; 6():493-501. PubMed ID: 22069360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How far is real life from COPD therapy guidelines? An Italian observational study.
    Corrado A; Rossi A
    Respir Med; 2012 Jul; 106(7):989-97. PubMed ID: 22483189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
    Ding B; Small M; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study.
    Barrecheguren M; Monteagudo M; Ferrer J; Borrell E; Llor C; Esquinas C; Miravitlles M
    Respir Med; 2016 Feb; 111():47-53. PubMed ID: 26758585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.
    Price D; Miravitlles M; Pavord I; Thomas M; Wedzicha J; Haughney J; Bichel K; West D
    NPJ Prim Care Respir Med; 2016 Nov; 26():16061. PubMed ID: 27808096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of COPD exacerbations in primary care: a clinical cohort study.
    Sundh J; Österlund Efraimsson E; Janson C; Montgomery S; Ställberg B; Lisspers K
    Prim Care Respir J; 2013 Dec; 22(4):393-9. PubMed ID: 24114334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.
    Fritsch K; Jacot ML; Klarer A; Wick F; Bruggmann P; Krause M; Thurnheer R
    Swiss Med Wkly; 2005 Feb; 135(7-8):116-21. PubMed ID: 15832228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy.
    Palmiotti GA; Lacedonia D; Liotino V; Schino P; Satriano F; Di Napoli PL; Sabato E; Mastrosimone V; Scoditti A; Carone M; Costantino E; Resta E; Attolini E; Foschino Barbaro MP
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2455-2462. PubMed ID: 30147311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.
    Contoli M; Corsico AG; Santus P; Di Marco F; Braido F; Rogliani P; Calzetta L; Scichilone N
    COPD; 2017 Dec; 14(6):641-647. PubMed ID: 29116901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.
    Stafyla E; Kotsiou OS; Deskata K; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2018; 13():487-498. PubMed ID: 29440886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.
    Miravitlles M; Mayordomo C; Artés M; Sánchez-Agudo L; Nicolau F; Segú JL
    Respir Med; 1999 Mar; 93(3):173-9. PubMed ID: 10464874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
    Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.